Lunai Bioworks Inc.
Public company- Headquarters
- SUITE 906 LOS ANGELES, California
- Ticker
- LNAI
- CIK
- 0001527728
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CFONathen Fuentes | Oct 23, 2026 | Departed |
| member of the BoardDouglas W. Calder | Oct 23, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
- Executive departure
CFO departs: Nathen Fuentes
Nathen Fuentes, Chief Financial Officer of Lunai Bioworks Inc., resigns the role, effective October 22, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 23, 2026Role: Chief Financial Officer
- Executive departure
member of the Board departs: Douglas W. Calder
Douglas W. Calder, member of the Board of Lunai Bioworks Inc., resigns the role, effective October 22, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 23, 2026Role: member of the Board
Last verified Nov 8, 2026